ENOV 8-K 2026-11-05
Enovis CORP (ENOV) 8-K dated 2026-11-05 — accession 0001420800-26-000052.
Enovis CORP (ENOV) is a medical devices company listed on US.
ENOV: Enovis Announces Third Quarter 2026 Results
This 8-K covers: Results of operations (Item 2.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported ENOV revenue for 2025-12-31 was $2.25B. Net income was -$1.18B. Revenue was up 6.7% from 2024-12-31 to 2025-12-31. ENOV currently screens at market cap $1.37B.
Not investment advice. The ENOV SEC hub lists recent forms. The stock page is the research view.
- Guidance
- full-year 2026 guidance for adjusted EBITDA and adjusted EPS
Why it matters
- full-year 2026 guidance for adjusted EBITDA and adjusted EPS
- Our third-quarter results reflect continued progress against our innovation-led strategy and the benefits of executing with greater alignment, accountability…